MSN | moesin | Xq11.1 | 0.465 | 0.623 | 0
|
PDE4B | phosphodiesterase 4B, cAMP-specific | 1p31 | 0.449 | 0.619 | 0
|
GLIPR1 | GLI pathogenesis-related 1 | 12q14.1 | 0.444 | 0.623 | 0
|
INHBA | inhibin, beta A | 7p15-p13 | 0.437 | 0.608 | 0
|
ITGA4 | integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor) | 2q31-q32 | 0.425 | 0.62 | 0
|
GNG2 | guanine nucleotide binding protein (G protein), gamma 2 | 14q21 | 0.424 | 0.547 | 0
|
ARSJ | arylsulfatase family, member J | 4q26 | 0.423 | 0.571 | 0
|
LCP2 | lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa) | 5q35.1 | 0.419 | 0.605 | 0
|
GNB4 | guanine nucleotide binding protein (G protein), beta polypeptide 4 | 3q27.1 | 0.417 | 0.57 | 0
|
FAS | Fas cell surface death receptor | 10q24.1 | 0.416 | 0.597 | 0
|
SAMSN1 | SAM domain, SH3 domain and nuclear localization signals 1 | 21q11 | 0.415 | 0.616 | 0
|
TNFAIP6 | tumor necrosis factor, alpha-induced protein 6 | 2q23.3 | 0.415 | 0.605 | 0
|
ITPRIP | inositol 1,4,5-trisphosphate receptor interacting protein | 10q25.1 | 0.415 | 0.683 | 0
|
F2R | coagulation factor II (thrombin) receptor | 5q13 | 0.412 | 0.535 | 0
|
ALOX5AP | arachidonate 5-lipoxygenase-activating protein | 13q12 | 0.411 | 0.543 | 0
|
CD14 | CD14 molecule | 5q31.3 | 0.41 | 0.497 | 0
|
BCL2A1 | BCL2-related protein A1 | 15q24.3 | 0.409 | 0.593 | 0
|
EDNRA | endothelin receptor type A | 4q31.22 | 0.406 | 0.51 | 0
|
PDCD1LG2 | programmed cell death 1 ligand 2 | 9p24.2 | 0.406 | 0.567 | 0
|
TGFBI | transforming growth factor, beta-induced, 68kDa | 5q31 | 0.405 | 0.57 | 0
|
RGS1 | regulator of G-protein signaling 1 | 1q31 | 0.405 | 0.613 | 0
|
RAB31 | RAB31, member RAS oncogene family | 18p11.22 | 0.405 | 0.514 | 0
|
NCF2 | neutrophil cytosolic factor 2 | 1q25 | 0.404 | 0.587 | 0
|
CCL4 | chemokine (C-C motif) ligand 4 | 17q12 | 0.403 | 0.577 | 0
|
ADAMTS4 | ADAM metallopeptidase with thrombospondin type 1 motif, 4 | 1q31-q32 | 0.401 | 0.547 | 0
|
GPR183 | G protein-coupled receptor 183 | 13q32.3 | 0.401 | 0.604 | 0
|
IL7R | interleukin 7 receptor | 5p13 | 0.399 | 0.658 | 0
|
IL10 | interleukin 10 | 1q31-q32 | 0.399 | 0.541 | 0
|
CD300C | CD300c molecule | 17q25.2 | 0.399 | 0.494 | 0
|
C5AR2 | complement component 5a receptor 2 | 19q13.33 | 0.399 | 0.584 | 0
|
PALM2-AKAP2 | PALM2-AKAP2 readthrough | 9q31.3 | 0.398 | 0.483 | 0
|
FCGR2A | Fc fragment of IgG, low affinity IIa, receptor (CD32) | 1q23 | 0.398 | 0.536 | 0
|
LILRB2 | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2 | 19q13.4 | 0.397 | 0.552 | 0
|
FLI1 | Fli-1 proto-oncogene, ETS transcription factor | 11q24.1-q24.3 | 0.395 | 0.524 | 0
|
TAGAP | T-cell activation RhoGTPase activating protein | 6q25.3 | 0.395 | 0.567 | 0
|
CHST11 | carbohydrate (chondroitin 4) sulfotransferase 11 | 12q23.3 | 0.395 | 0.535 | 0
|
CCDC71L | coiled-coil domain containing 71-like | 7q22.3 | 0.395 | 0.546 | 0
|
RFTN1 | raftlin, lipid raft linker 1 | 3p24.3 | 0.394 | 0.503 | 0
|
CHST15 | carbohydrate (N-acetylgalactosamine 4-sulfate 6-O) sulfotransferase 15 | 10q26 | 0.394 | 0.558 | 0
|
SULF2 | sulfatase 2 | 20q13.12 | 0.394 | 0.521 | 0
|
FYB | FYN binding protein | 5p13.1 | 0.394 | 0.574 | 0
|
SIRPA | signal-regulatory protein alpha | 20p13 | 0.393 | 0.539 | 0
|
OSMR | oncostatin M receptor | 5p13.2 | 0.393 | 0.53 | 0
|
SLC2A3 | solute carrier family 2 (facilitated glucose transporter), member 3 | 12p13.3 | 0.392 | 0.561 | 0
|
ADAMTS2 | ADAM metallopeptidase with thrombospondin type 1 motif, 2 | 5q35.3 | 0.392 | 0.51 | 0
|
TNFAIP3 | tumor necrosis factor, alpha-induced protein 3 | 6q23-q25 | 0.39 | 0.636 | 0
|
TRPV2 | transient receptor potential cation channel, subfamily V, member 2 | 17p11.2 | 0.39 | 0.503 | 0
|
ZNF469 | zinc finger protein 469 | 16q24 | 0.389 | 0.51 | 0
|
CDK6 | cyclin-dependent kinase 6 | 7q21-q22 | 0.389 | 0.53 | 0
|
ITGA1 | integrin, alpha 1 | 5q11.1 | 0.388 | 0.483 | 0
|
KLHL5 | kelch-like family member 5 | 4p15.1 | 0.387 | 0.534 | 0
|
PRR16 | proline rich 16 | 5q23.1 | 0.387 | 0.517 | 0
|
OSM | oncostatin M | 22q12.2 | 0.386 | 0.619 | 0
|
TNC | tenascin C | 9q33.1 | 0.385 | 0.54 | 0
|
TNFRSF9 | tumor necrosis factor receptor superfamily, member 9 | 1p36 | 0.385 | 0.583 | 0
|
SIGLEC10 | sialic acid binding Ig-like lectin 10 | 19q13.3 | 0.385 | 0.52 | 0
|
ZNF443 | zinc finger protein 443 | 19p13.13 | 0.384 | -0.458 | 0
|
FPR2 | formyl peptide receptor 2 | 19q13.3-q13.4 | 0.384 | 0.545 | 0
|
TNIP3 | TNFAIP3 interacting protein 3 | 4q27 | 0.384 | 0.601 | 0
|
CREB5 | cAMP responsive element binding protein 5 | 7p15 | 0.384 | 0.557 | 0
|
MEFV | Mediterranean fever | 16p13.3 | 0.383 | 0.577 | 0
|
GBP5 | guanylate binding protein 5 | 1p22.2 | 0.383 | 0.575 | 0
|
PLAUR | plasminogen activator, urokinase receptor | 19q13 | 0.382 | 0.645 | 0
|
ST8SIA4 | ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4 | 5q21 | 0.381 | 0.534 | 0
|
VIM | vimentin | 10p13 | 0.381 | 0.521 | 0
|
TLR6 | toll-like receptor 6 | 4p16.1 | 0.38 | 0.539 | 0
|
CYTIP | cytohesin 1 interacting protein | 2q11.2 | 0.38 | 0.602 | 0
|
SLC2A14 | solute carrier family 2 (facilitated glucose transporter), member 14 | 12p13.31 | 0.38 | 0.534 | 0
|
CD80 | CD80 molecule | 3q13.3-q21 | 0.379 | 0.586 | 0
|
FAM167A | family with sequence similarity 167, member A | 8p23-p22 | 0.379 | 0.555 | 0
|
CD109 | CD109 molecule | 6q14.1 | 0.378 | 0.505 | 0
|
LATS2 | large tumor suppressor kinase 2 | 13q12.11 | 0.378 | 0.512 | 0
|
SULF1 | sulfatase 1 | 8q13.2 | 0.378 | 0.415 | 0
|
GATA3-AS1 | GATA3 antisense RNA 1 | 10p14 | 0.375 | -0.472 | 0
|
PTPN22 | protein tyrosine phosphatase, non-receptor type 22 (lymphoid) | 1p13.2 | 0.374 | 0.578 | 0
|
SOCS3 | suppressor of cytokine signaling 3 | 17q25.3 | 0.372 | 0.589 | 0
|
PLEK | pleckstrin | 2p13.3 | 0.372 | 0.52 | 0
|
DPP4 | dipeptidyl-peptidase 4 | 2q24.2 | 0.371 | 0.516 | 0
|
MYO5A | myosin VA | 15q21 | 0.37 | 0.474 | 0
|
CLMP | CXADR-like membrane protein | 11q24 | 0.369 | 0.488 | 0
|
HS3ST3B1 | heparan sulfate (glucosamine) 3-O-sulfotransferase 3B1 | 17p12 | 0.368 | 0.587 | 0
|
SUSD6 | sushi domain containing 6 | 14q24.1 | 0.367 | 0.576 | 0
|
ECM1 | extracellular matrix protein 1 | 1q21 | 0.367 | 0.575 | 0
|
CAMK4 | calcium/calmodulin-dependent protein kinase IV | 5q22.1 | 0.367 | 0.523 | 0
|
CCL3 | chemokine (C-C motif) ligand 3 | 17q12 | 0.366 | 0.524 | 0
|
COL5A3 | collagen, type V, alpha 3 | 19p13.2 | 0.366 | 0.491 | 0
|
SOD2 | superoxide dismutase 2, mitochondrial | 6q25 | 0.366 | 0.536 | 0
|
F3 | coagulation factor III (thromboplastin, tissue factor) | 1p22-p21 | 0.365 | 0.574 | 0
|
WWTR1 | WW domain containing transcription regulator 1 | 3q23-q24 | 0.363 | 0.441 | 0
|
TM7SF2 | transmembrane 7 superfamily member 2 | 11q13.1 | 0.363 | -0.489 | 0
|
ZBED2 | zinc finger, BED-type containing 2 | 3p13-q13.2 | 0.362 | 0.547 | 0
|
EMP1 | epithelial membrane protein 1 | 12p13.1 | 0.362 | 0.529 | 0
|
VSNL1 | visinin-like 1 | 2p24.3 | 0.362 | 0.495 | 0
|
PTHLH | parathyroid hormone-like hormone | 12p12.1-p11.2 | 0.362 | 0.559 | 0
|
CD44 | CD44 molecule (Indian blood group) | 11p13 | 0.361 | 0.512 | 0
|
NOD2 | nucleotide-binding oligomerization domain containing 2 | 16q12 | 0.361 | 0.531 | 0
|
RAB27A | RAB27A, member RAS oncogene family | 15q21.3 | 0.36 | 0.517 | 0
|
ZSCAN16 | zinc finger and SCAN domain containing 16 | 6p21.33 | 0.36 | -0.501 | 0
|
GATA3 | GATA binding protein 3 | 10p15 | 0.36 | -0.444 | 0
|
SARM1 | sterile alpha and TIR motif containing 1 | 17q11 | 0.359 | -0.488 | 0
|
LTBP2 | latent transforming growth factor beta binding protein 2 | 14q24.3 | 0.358 | 0.449 | 0
|
CSF1 | colony stimulating factor 1 (macrophage) | 1p13.3 | 0.357 | 0.533 | 0
|
NR3C1 | nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 5q31-q32 | 0.355 | 0.501 | 0
|
DSE | dermatan sulfate epimerase | 6q22 | 0.354 | 0.529 | 0
|
CAV2 | caveolin 2 | 7q31 | 0.354 | 0.454 | 0
|
PDPN | podoplanin | 1p36.21 | 0.353 | 0.567 | 0
|
SFI1 | SFI1 centrin binding protein | 22q12.2 | 0.353 | -0.446 | 0
|
TREM1 | triggering receptor expressed on myeloid cells 1 | 6p21.1 | 0.353 | 0.514 | 0
|
RNF145 | ring finger protein 145 | 5q33.3 | 0.352 | 0.477 | 0
|
CSGALNACT2 | chondroitin sulfate N-acetylgalactosaminyltransferase 2 | 10q11.21 | 0.352 | 0.494 | 0
|
GRAMD1B | GRAM domain containing 1B | 11q24.1 | 0.352 | 0.541 | 0
|
PLAU | plasminogen activator, urokinase | 10q24 | 0.35 | 0.524 | 0
|
CLEC5A | C-type lectin domain family 5, member A | 7q34 | 0.349 | 0.505 | 0
|
CREB3L4 | cAMP responsive element binding protein 3-like 4 | 1q21.2 | 0.348 | -0.489 | 0
|
MCTP1 | multiple C2 domains, transmembrane 1 | 5q15 | 0.348 | 0.439 | 0
|
IL1R2 | interleukin 1 receptor, type II | 2q12 | 0.346 | 0.463 | 0
|
NT5E | 5'-nucleotidase, ecto (CD73) | 6q14-q21 | 0.346 | 0.419 | 0
|
TMEM26 | transmembrane protein 26 | 10q21.3 | 0.345 | 0.493 | 0
|
SGK1 | serum/glucocorticoid regulated kinase 1 | 6q23 | 0.345 | 0.558 | 0
|
FRMD4B | FERM domain containing 4B | 3p14.2 | 0.345 | 0.527 | 0
|
NID1 | nidogen 1 | 1q43 | 0.345 | 0.423 | 0
|
CDK5RAP3 | CDK5 regulatory subunit associated protein 3 | 17q21.2 | 0.345 | -0.402 | 0
|
ZNF709 | zinc finger protein 709 | 19p13.2 | 0.345 | -0.505 | 0
|
TPP1 | tripeptidyl peptidase I | 11p15.4 | 0.344 | 0.435 | 0
|
TRIM22 | tripartite motif containing 22 | 11p15 | 0.344 | 0.55 | 0
|
NRP1 | neuropilin 1 | 10p12 | 0.344 | 0.507 | 0
|
ZNF768 | zinc finger protein 768 | 16p11.2 | 0.344 | -0.485 | 0
|
CRACR2B | calcium release activated channel regulator 2B | 11p15.5 | 0.344 | -0.413 | 0
|
MMP14 | matrix metallopeptidase 14 (membrane-inserted) | 14q11-q12 | 0.344 | 0.418 | 0
|
CYLD | cylindromatosis (turban tumor syndrome) | 16q12.1 | 0.344 | 0.521 | 0
|
PCNX | pecanex homolog (Drosophila) | 14q24.2 | 0.343 | 0.427 | 0
|
ACP6 | acid phosphatase 6, lysophosphatidic | 1q21 | 0.343 | -0.497 | 0
|
EGR3 | early growth response 3 | 8p23-p21 | 0.343 | 0.507 | 0
|
OSTM1 | osteopetrosis associated transmembrane protein 1 | 6q21 | 0.342 | 0.489 | 0
|
ELK3 | ELK3, ETS-domain protein (SRF accessory protein 2) | 12q23 | 0.341 | 0.533 | 0
|
STK17B | serine/threonine kinase 17b | 2q33.1 | 0.341 | 0.6 | 0
|
MGC12916 | | | 0.34 | 0.564 | 0
|
CFLAR | CASP8 and FADD-like apoptosis regulator | 2q33-q34 | 0.34 | 0.526 | 0
|
DCBLD1 | discoidin, CUB and LCCL domain containing 1 | 6q22.31 | 0.339 | 0.469 | 0
|
C20orf96 | chromosome 20 open reading frame 96 | 20p13 | 0.339 | -0.501 | 0
|
SAMD9L | sterile alpha motif domain containing 9-like | 7q21.2 | 0.339 | 0.53 | 0
|
STK17A | serine/threonine kinase 17a | 7p13 | 0.339 | 0.551 | 0
|
PNMT | phenylethanolamine N-methyltransferase | 17q12 | 0.337 | -0.431 | 0
|
MYO1B | myosin IB | 2q12-q34 | 0.337 | 0.503 | 0
|
HMGA2 | high mobility group AT-hook 2 | 12q15 | 0.337 | 0.472 | 0
|
FAM129A | family with sequence similarity 129, member A | 1q25 | 0.335 | 0.383 | 9.84e-17
|
FSD1L | fibronectin type III and SPRY domain containing 1-like | 9q31 | 0.335 | 0.385 | 2.99e-17
|
PGAP3 | post-GPI attachment to proteins 3 | 17q21.2 | 0.334 | -0.373 | 1.45e-15
|
TRPM5 | transient receptor potential cation channel, subfamily M, member 5 | 11p15.5 | 0.334 | -0.367 | 5.32e-15
|
KLF7 | Kruppel-like factor 7 (ubiquitous) | 2q32 | 0.334 | 0.418 | 0
|
FAM69A | family with sequence similarity 69, member A | 1p22 | 0.333 | 0.444 | 0
|
PAPPA | pregnancy-associated plasma protein A, pappalysin 1 | 9q33.1 | 0.333 | 0.571 | 0
|
ELL2 | elongation factor, RNA polymerase II, 2 | 5q15 | 0.333 | 0.505 | 0
|
GBP1 | guanylate binding protein 1, interferon-inducible | 1p22.2 | 0.333 | 0.504 | 0
|
BACH1 | BTB and CNC homology 1, basic leucine zipper transcription factor 1 | 21q22.1 | 0.333 | 0.456 | 0
|
KRT6A | keratin 6A, type II | 12q13.13 | 0.332 | 0.403 | 0
|
KLF10 | Kruppel-like factor 10 | 8q22.3 | 0.332 | 0.464 | 0
|
NRG1 | neuregulin 1 | 8p12 | 0.331 | 0.522 | 0
|
HIF1A | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 14q23.2 | 0.331 | 0.507 | 0
|
FAM43A | family with sequence similarity 43, member A | 3q29 | 0.33 | 0.505 | 0
|
SAMD4A | sterile alpha motif domain containing 4A | 14q22.2 | 0.33 | 0.375 | 9.69e-16
|
GALNT10 | polypeptide N-acetylgalactosaminyltransferase 10 | 5q34 | 0.33 | 0.462 | 0
|
NUAK2 | NUAK family, SNF1-like kinase, 2 | 1q32.1 | 0.329 | 0.531 | 0
|
ZBTB12 | zinc finger and BTB domain containing 12 | 6p21.31 | 0.329 | -0.502 | 0
|
MCL1 | myeloid cell leukemia 1 | 1q21 | 0.328 | 0.571 | 0
|
RND3 | Rho family GTPase 3 | 2q23.3 | 0.328 | 0.481 | 0
|
HBEGF | heparin-binding EGF-like growth factor | 5q23 | 0.327 | 0.566 | 0
|
ADGRE2 | adhesion G protein-coupled receptor E2 | 19p13.12 | 0.327 | 0.427 | 0
|
MAF | v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog | 16q22-q23 | 0.325 | 0.5 | 0
|
CXCL1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) | 4q13.3 | 0.325 | 0.478 | 0
|
LRRC8C | leucine rich repeat containing 8 family, member C | 1p22.2 | 0.325 | 0.498 | 0
|
THSD1 | thrombospondin, type I, domain containing 1 | 13q14.13 | 0.324 | 0.442 | 0
|
ACTR3 | ARP3 actin-related protein 3 homolog (yeast) | 2q14.1 | 0.324 | 0.44 | 0
|
BDKRB2 | bradykinin receptor B2 | 14q32.1-q32.2 | 0.323 | 0.505 | 0
|
DUSP1 | dual specificity phosphatase 1 | 5q35.1 | 0.323 | 0.498 | 0
|
SERPINE1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | 7q22.1 | 0.323 | 0.453 | 0
|
CTSC | cathepsin C | 11q14.2 | 0.323 | 0.447 | 0
|
RNF19B | ring finger protein 19B | 1p35.1 | 0.322 | 0.516 | 0
|
CD82 | CD82 molecule | 11p11.2 | 0.322 | 0.504 | 0
|
GTF2IRD2B | GTF2I repeat domain containing 2B | 7q11.23 | 0.32 | -0.413 | 0
|
CCDC57 | coiled-coil domain containing 57 | 17q25.3 | 0.319 | -0.404 | 0
|
PHLDA1 | pleckstrin homology-like domain, family A, member 1 | 12q15 | 0.319 | 0.602 | 0
|
GSDMC | gasdermin C | 8q24.21 | 0.319 | 0.456 | 0
|
ASAP1 | ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 | 8q24.1-q24.2 | 0.319 | 0.309 | 8.54e-11
|
ITGAV | integrin, alpha V | 2q31-q32 | 0.317 | 0.44 | 0
|
SLC37A4 | solute carrier family 37 (glucose-6-phosphate transporter), member 4 | 11q23.3 | 0.317 | -0.432 | 0
|
SFMBT2 | Scm-like with four mbt domains 2 | 10p15.1 | 0.317 | 0.407 | 0
|
HES2 | hes family bHLH transcription factor 2 | 1p36.31 | 0.317 | 0.373 | 1.38e-15
|
MB21D1 | Mab-21 domain containing 1 | 6q13 | 0.316 | 0.4 | 0
|
ATXN1 | ataxin 1 | 6p23 | 0.316 | 0.474 | 0
|
LRTOMT | leucine rich transmembrane and O-methyltransferase domain containing | 11q13.4 | 0.315 | -0.454 | 0
|
FLJ37453 | | | 0.313 | -0.513 | 0
|
NUAK1 | NUAK family, SNF1-like kinase, 1 | 12q23.3 | 0.313 | 0.381 | 1.89e-16
|
IL36G | interleukin 36, gamma | 2q12-q21 | 0.313 | 0.325 | 7.91e-12
|
MCEMP1 | mast cell-expressed membrane protein 1 | 19p13.2 | 0.312 | 0.386 | 5e-18
|
STK38L | serine/threonine kinase 38 like | 12p11.23 | 0.31 | 0.416 | 0
|
GDF9 | growth differentiation factor 9 | 5q31.1 | 0.31 | -0.415 | 0
|
NDST1 | N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1 | 5q33.1 | 0.309 | 0.383 | 8.79e-17
|
BHLHE40 | basic helix-loop-helix family, member e40 | 3p26 | 0.309 | 0.506 | 0
|
MRPS25 | mitochondrial ribosomal protein S25 | 3p25 | 0.308 | -0.405 | 0
|
NCOA7 | nuclear receptor coactivator 7 | 6q22.33 | 0.308 | 0.509 | 0
|
ZSWIM1 | zinc finger, SWIM-type containing 1 | 20q13.12 | 0.308 | -0.437 | 0
|
S100A8 | S100 calcium binding protein A8 | 1q12-q22 | 0.307 | 0.425 | 0
|
CXCL3 | chemokine (C-X-C motif) ligand 3 | 4q21 | 0.307 | 0.473 | 0
|
STARD4 | StAR-related lipid transfer (START) domain containing 4 | 5q22 | 0.306 | 0.451 | 0
|
FUZ | fuzzy planar cell polarity protein | 19q13.33 | 0.304 | -0.443 | 0
|
C2orf81 | chromosome 2 open reading frame 81 | 2p13.1 | 0.303 | -0.429 | 0
|
RHCG | Rh family, C glycoprotein | 15q25 | 0.303 | 0.361 | 1.67e-14
|
IL24 | interleukin 24 | 1q32 | 0.302 | 0.466 | 0
|
C8orf44 | chromosome 8 open reading frame 44 | 8q13.1 | 0.302 | -0.415 | 0
|
TXNRD2 | thioredoxin reductase 2 | 22q11.21 | 0.3 | -0.089 | 0.0662
|
C10orf55 | chromosome 10 open reading frame 55 | 10q22.2 | 0.3 | 0.455 | 0
|
FAM83A-AS1 | FAM83A antisense RNA 1 | 8q24.13 | 0.299 | 0.276 | 7.27e-09
|
CSF2 | colony stimulating factor 2 (granulocyte-macrophage) | 5q23-q31 | 0.299 | 0.424 | 0
|
NIN | ninein (GSK3B interacting protein) | 14q21-q22 | 0.299 | 0.395 | 0
|
ITGA2 | integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) | 5q11.2 | 0.299 | 0.401 | 0
|
ACBD7 | acyl-CoA binding domain containing 7 | 10p13 | 0.298 | -0.388 | 0
|
TSEN54 | TSEN54 tRNA splicing endonuclease subunit | 17q25.1 | 0.297 | -0.398 | 0
|
OVOL2 | ovo-like zinc finger 2 | 20p11.23 | 0.297 | -0.342 | 5.28e-13
|
FRMD6 | FERM domain containing 6 | 14q22.1 | 0.297 | 0.39 | 0
|
ATP6V0E2-AS1 | ATP6V0E2 antisense RNA 1 | 7q36.1 | 0.297 | -0.406 | 0
|
RIPPLY3 | ripply transcriptional repressor 3 | 21q22.2 | 0.296 | -0.416 | 0
|
CXCL8 | chemokine (C-X-C motif) ligand 8 | 4q13-q21 | 0.296 | 0.542 | 0
|
IRF6 | interferon regulatory factor 6 | 1q32.2-q32.3 | 0.292 | 0.301 | 2.52e-10
|
AKAP13 | A kinase (PRKA) anchor protein 13 | 15q24-q25 | 0.291 | 0.424 | 0
|
FURIN | furin (paired basic amino acid cleaving enzyme) | 15q26.1 | 0.291 | 0.318 | 2.16e-11
|
NECAB3 | N-terminal EF-hand calcium binding protein 3 | 20q11.21 | 0.291 | -0.463 | 0
|
ZNF48 | zinc finger protein 48 | 16p11.2 | 0.29 | -0.486 | 0
|
PNRC1 | proline-rich nuclear receptor coactivator 1 | 6q16.1 | 0.289 | 0.389 | 0
|
TPM4 | tropomyosin 4 | 19p13.1 | 0.289 | 0.419 | 0
|
SLC16A8 | solute carrier family 16 (monocarboxylate transporter), member 8 | 22q12.3-q13.2 | 0.288 | -0.359 | 2.74e-14
|
SLC10A6 | solute carrier family 10 (sodium/bile acid cotransporter), member 6 | 4q22.1 | 0.288 | 0.401 | 0
|
IER3 | immediate early response 3 | 6p21.3 | 0.287 | 0.512 | 0
|
AFMID | arylformamidase | 17q25.3 | 0.286 | -0.444 | 0
|
SPSB1 | splA/ryanodine receptor domain and SOCS box containing 1 | 1p36.22 | 0.284 | 0.276 | 7.99e-09
|
VNN3 | vanin 3 | 6q23.2 | 0.282 | 0.449 | 0
|
MOB3A | MOB kinase activator 3A | 19p13.3 | 0.281 | 0.374 | 1.33e-15
|
STC1 | stanniocalcin 1 | 8p21.2 | 0.28 | 0.462 | 0
|
HTR7 | 5-hydroxytryptamine (serotonin) receptor 7, adenylate cyclase-coupled | 10q21-q24 | 0.279 | 0.318 | 2.17e-11
|
MYH9 | myosin, heavy chain 9, non-muscle | 22q13.1 | 0.279 | 0.403 | 0
|
ALKBH4 | alkB homolog 4, lysine demthylase | 7q22.1 | 0.279 | -0.436 | 0
|
PPIL6 | peptidylprolyl isomerase (cyclophilin)-like 6 | 6q21 | 0.278 | -0.378 | 4.34e-16
|
C19orf57 | chromosome 19 open reading frame 57 | 19p13.12 | 0.277 | -0.265 | 3.02e-08
|
SAT1 | spermidine/spermine N1-acetyltransferase 1 | Xp22.1 | 0.277 | 0.474 | 0
|
MMP1 | matrix metallopeptidase 1 | 11q22.2 | 0.275 | 0.399 | 0
|
ANKRD16 | ankyrin repeat domain 16 | 10p15.1 | 0.274 | -0.316 | 2.93e-11
|
UACA | uveal autoantigen with coiled-coil domains and ankyrin repeats | 15q22-q24 | 0.273 | 0.403 | 0
|
BDKRB1 | bradykinin receptor B1 | 14q32.1-q32.2 | 0.272 | 0.432 | 0
|
MED29 | mediator complex subunit 29 | 19q13.2 | 0.271 | -0.411 | 0
|
UBE2J1 | ubiquitin-conjugating enzyme E2, J1 | 6q15 | 0.27 | 0.417 | 0
|
C21orf33 | chromosome 21 open reading frame 33 | 21q22.3 | 0.27 | -0.327 | 5.36e-12
|
C19orf54 | chromosome 19 open reading frame 54 | 19q13.2 | 0.269 | -0.351 | 1.13e-13
|
MACROD1 | MACRO domain containing 1 | 11q13.1 | 0.267 | -0.363 | 1.14e-14
|
GTSE1-AS1 | GTSE1 antisense RNA 1 (head to head) | 22q13.31 | 0.265 | -0.346 | 2.6e-13
|
BZW1 | basic leucine zipper and W2 domains 1 | 2q33 | 0.264 | 0.353 | 7.67e-14
|
GNMT | glycine N-methyltransferase | 6p12 | 0.264 | -0.253 | 1.28e-07
|
COL27A1 | collagen, type XXVII, alpha 1 | 9q33.1 | 0.263 | 0.347 | 2.06e-13
|
C1orf56 | chromosome 1 open reading frame 56 | 1q21.2 | 0.263 | -0.305 | 1.58e-10
|
IL1RL1 | interleukin 1 receptor-like 1 | 2q12 | 0.262 | 0.405 | 0
|
PPP1R1B | protein phosphatase 1, regulatory (inhibitor) subunit 1B | 17q12 | 0.261 | -0.248 | 2.35e-07
|
PXMP4 | peroxisomal membrane protein 4, 24kDa | 20q11.22 | 0.261 | -0.343 | 4.4e-13
|
XG | Xg blood group | Xp22.32 | 0.26 | 0.358 | 2.82e-14
|
KCNJ2 | potassium channel, inwardly rectifying subfamily J, member 2 | 17q24.3 | 0.259 | 0.436 | 0
|
HIRIP3 | HIRA interacting protein 3 | 16p12.1 | 0.258 | -0.412 | 0
|
TRAIP | TRAF interacting protein | 3p21.31 | 0.257 | -0.274 | 9.58e-09
|
SBNO2 | strawberry notch homolog 2 (Drosophila) | 19p13.3 | 0.257 | 0.411 | 0
|
SLC28A3 | solute carrier family 28 (concentrative nucleoside transporter), member 3 | 9q21.33 | 0.257 | 0.339 | 8.7e-13
|
KIF22 | kinesin family member 22 | 16p11.2 | 0.256 | -0.33 | 3.8e-12
|
C16orf58 | chromosome 16 open reading frame 58 | 16p11.2 | 0.256 | -0.299 | 3.37e-10
|
SYF2 | SYF2 pre-mRNA-splicing factor | 1p36.11 | 0.255 | -0.322 | 1.27e-11
|
SUV420H2 | suppressor of variegation 4-20 homolog 2 (Drosophila) | 19q13.42 | 0.255 | -0.289 | 1.47e-09
|
GABPB1 | GA binding protein transcription factor, beta subunit 1 | 15q21.2 | 0.254 | 0.175 | 0.000289
|
GATS | GATS, stromal antigen 3 opposite strand | 7q22.1 | 0.253 | -0.309 | 8.4e-11
|
ALDH1A3 | aldehyde dehydrogenase 1 family, member A3 | 15q26.3 | 0.253 | 0.345 | 2.84e-13
|
LACTB | lactamase, beta | 15q22.1 | 0.251 | 0.3 | 2.97e-10
|
CEMIP | cell migration inducing protein, hyaluronan binding | 15q25.1 | 0.248 | 0.393 | 0
|
RRP7BP | ribosomal RNA processing 7 homolog B, pseudogene | 22q13.2 | 0.247 | -0.245 | 3.35e-07
|
PTGS2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | 1q25.2-q25.3 | 0.246 | 0.329 | 4.41e-12
|
LINC00634 | long intergenic non-protein coding RNA 634 | 22q13.2 | 0.244 | -0.275 | 9.02e-09
|
IL1A | interleukin 1, alpha | 2q14 | 0.243 | 0.323 | 9.88e-12
|
NDEL1 | nudE neurodevelopment protein 1-like 1 | 17p13.1 | 0.243 | 0.355 | 5.37e-14
|
MCM3 | minichromosome maintenance complex component 3 | 6p12 | 0.24 | -0.246 | 2.76e-07
|
DST | dystonin | 6p12.1 | 0.24 | 0.232 | 1.41e-06
|
IL1B | interleukin 1, beta | 2q14 | 0.239 | 0.43 | 0
|
PTEN | phosphatase and tensin homolog | 10q23 | 0.238 | 0.319 | 1.88e-11
|
ARHGEF3 | Rho guanine nucleotide exchange factor (GEF) 3 | 3p14.3 | 0.236 | 0.366 | 6.36e-15
|
GIT1 | G protein-coupled receptor kinase interacting ArfGAP 1 | 17p11.2 | 0.231 | -0.279 | 5.43e-09
|
PDRG1 | p53 and DNA-damage regulated 1 | 20q11.21 | 0.231 | -0.335 | 1.55e-12
|
RHPN1-AS1 | RHPN1 antisense RNA 1 (head to head) | 8q24 | 0.228 | -0.365 | 8.2e-15
|
TMEM80 | transmembrane protein 80 | 11p15.5 | 0.228 | -0.226 | 2.52e-06
|
NFYC | nuclear transcription factor Y, gamma | 1p32 | 0.227 | -0.28 | 4.87e-09
|
APOBEC3A | apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A | 22q13.1-q13.2 | 0.225 | 0.406 | 0
|
SLC26A9 | solute carrier family 26 (anion exchanger), member 9 | 1q32.1 | 0.224 | 0.306 | 1.22e-10
|
ASB13 | ankyrin repeat and SOCS box containing 13 | 10p15.1 | 0.22 | -0.276 | 8.12e-09
|
DCUN1D3 | DCN1, defective in cullin neddylation 1, domain containing 3 | 16p12.3 | 0.213 | 0.297 | 4.59e-10
|
PPP3CB | protein phosphatase 3, catalytic subunit, beta isozyme | 10q22.2 | 0.211 | 0.281 | 4.2e-09
|